Home/News/Details

RAC-78 Meeting: Maintains Non-Carcinogenic Classification of Glyphosate and Advances Risk Assessment for Multiple Chemicals

Sep 20, 2026
EU
CLH
Favorite
Share
Unlock exclusive content and benefits? Sign up for free today!

From September 7 to 11, 2026, the Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA) held its 78th plenary meeting. The committee conducted in-depth deliberations on multiple core chemical regulatory topics and reached important consensus in key areas such as the carcinogenicity assessment of glyphosate, the setting of occupational exposure limits for lithium compounds, and the harmonized classification and labeling (CLH) of multiple chemicals. Based on the meeting minutes, CIRS Group provides the following interpretation.

Core Content

1. Carcinogenicity Assessment of Glyphosate

RAC finally concluded that the data from the Global Glyphosate Study (GGS) published by the Ramazzini Institute does not itself meet the criteria for carcinogen classification under the CLP Regulation. Therefore, it decided to maintain the "not classified as a carcinogen" conclusion made in 2022. This opinion is expected to be formally adopted by January 1, 2027.

2. Occupational Exposure Limits (OELs) for Lithium Compounds

  • Substances assessed: Lithium carbonate, lithium chloride, lithium hydroxide.
  • Developmental toxicity: Based on the key human study by Patorno et al. (2017), LOAEL 600 mg LiCO/d, 8h-TWA = 1.3 mg Li/m³ (considering an additional assessment factor of 3 for neurodevelopment).
  • Kidney and other organ toxicity: LOAEL 600 mg LiCO/d, 8h-TWA = 3.8 mg Li/m³.
  • Fertility: Qualitative statement only; no 8h-TWA is proposed.
  • Local irritation: Calculated two STEL values separately (one for lithium hydroxide and one for other non-corrosive lithium compounds).
  • Next steps: STEL values, biological monitoring, analytical methods, etc., will continue to be discussed in the RAC-79 plenary meeting.

3. Harmonized Classification and Labeling (CLH)

Category A (Adopted without plenary debate, 12 items):

  • 1,1,3,3-Tetramethylbutyl peroxyneodecanoate: Reproductive toxicity.
  • Various resin acid substances: Reproductive toxicity (8 items in total).
  • 3-(Diethylamino)propylamine: Acute toxicity, Specific target organ toxicity-repeated exposure, Reproductive toxicity.
  • 3-(Dimethylamino)propylamine: Acute oral toxicity, Specific target organ toxicity-single exposure.
  • Reaction product of boric acid, didecylamine, and ethylene oxide: Multiple hazards.
  • Flutolanil: Multiple hazards.
  • Flocoumafen: Acute toxicity ATE.
  • 2,2-Dimethyl-3-morpholinopropionaldehyde: Skin corrosion/irritation, Eye damage/irritation, Skin sensitization.
  • 4-Morpholinecarboxaldehyde: Skin sensitization.
  • Reaction product of 2,2-dimethyl-3-morpholinopropionaldehyde and propylidynetrimethanol: Eye damage/irritation, Skin sensitization.

Category B (Requiring plenary debate, 7 items):

  • 3-(Diethylamino)propylamine: Classified as Acute Tox. 4, Acute Tox. 3, Skin Sens. 1, Repr. 1B; Endocrine disruption (human health and environment) left for discussion at RAC-79.
  • 3-(Dimethylamino)propylamine (DMAPA): Classified as Acute Tox. 4, Acute Tox. 3, Skin Sens. 1A, STOT SE 3, Repr. 2; Developmental toxicity, STOT RE, and endocrine disruption left for discussion at RAC-79.
  • Reaction product of boric acid, didecylamine, and ethylene oxide: Classified as Acute Tox. 4, Skin Corr. 1C, Eye Dam. 1, Skin Sens. 1A, Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1, etc.
  • Propylparaben: Classified as Endocrine Disruptor 1 (Environment), Aquatic Chronic 2.
  • Bromuconazole: Classified as Repr. 2 (other hazard classes already adopted at RAC-77).
  • Spearmint oil: Classified as Aquatic Chronic 3 (other classes already adopted at RAC-77).
  • Fenazaquin: Classified as Repr. 2 (other classes already adopted at RAC-77).

ChemRadar Insights

Enterprises in the chemical, daily chemical, pesticide, and coating industries should verify whether they use or produce the 19 CLH substances classified in this meeting and promptly initiate updates to labels and Safety Data Sheets (SDS). Lithium battery and lithium chemical enterprises need to plan ahead and initiate workplace exposure monitoring and health surveillance system construction.

 

Further information

ECHA

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.

4. CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. ChemRadar is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS’s current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.

Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
4.
CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. ChemRadar is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS's current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.
icon-server
message
in